DARUNAVIR
| Brand name | PREZISTA |
|---|---|
| Active ingredient | DARUNAVIR |
| Strength | 100MG/ML |
| Dosage form | SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | December 2011 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7700645*PED | June 2027 | — |
| 7700645 | December 2026 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.